Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Applied Micro Circuits Corp (AMCC) -- Ignore unavailable to you. Want to Upgrade?

To: Lutz Moeller who wrote (373)	2/25/2000 1:26:00 PM
From: Brian Sullivan	Read Replies (2) \| Respond to of 1805

I believe that he meant to type ALXN, "Alexion Pharmaceuticals". Guy loves stocks that have a strong thread-line. Everyone of the stocks that he is in have an awesome looking chart. ALXN is the only non-Tech stock in his list. Here is a business summary from one of their recent press releases: Alexion is engaged in the discovery and development of products for the treatment of cardiovascular, autoimmune and neurologic diseases caused by undesired effects of the human immune system. Alexion's two lead product candidates are currently in seven clinical development programs. 5G1.1-SC, in collaboration with Procter & Gamble, is in a Phase IIb cardiopulmonary bypass efficacy trial and in two Phase II myocardial infarction efficacy trials. 5G1.1 is in a Phase II efficacy trial for the chronic treatment of rheumatoid arthritis, a Phase II efficacy trial for the chronic treatment of membranous nephritis and it is commencing a Phase Ib pilot study for treatment of psoriasis and a Phase Ib pilot study for treatment of dermatomyositis. This press release and further information about Alexion Pharmaceuticals, Inc. can be found on the World Wide Web at: www.AlexionPharm.com .